Business
Press Release Nov 10 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 10, 2021, titled "press release dated November 10, 2021 titled Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection ".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 10, 2021, titled \"press release dated November 10, 2021 titled Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection \". View Attachment","length":389,"tagName":"div"}]